Search Results - "ZEH, H. J"

Refine Results
  1. 1

    The Beclin 1 network regulates autophagy and apoptosis by Kang, R, Zeh, H J, Lotze, M T, Tang, D

    Published in Cell death and differentiation (01-04-2011)
    “…Beclin 1, the mammalian orthologue of yeast Atg6, has a central role in autophagy, a process of programmed cell survival, which is increased during periods of…”
    Get full text
    Journal Article
  2. 2

    The HMGB1/RAGE inflammatory pathway promotes pancreatic tumor growth by regulating mitochondrial bioenergetics by Kang, R, Tang, D, Schapiro, N E, Loux, T, Livesey, K M, Billiar, T R, Wang, H, Van Houten, B, Lotze, M T, Zeh, H J

    Published in Oncogene (30-01-2014)
    “…Tumor cells require increased adenosine triphosphate (ATP) to support anabolism and proliferation. The precise mechanisms regulating this process in tumor…”
    Get full text
    Journal Article
  3. 3

    Strange attractors: DAMPs and autophagy link tumor cell death and immunity by Hou, W, Zhang, Q, Yan, Z, Chen, R, Zeh III, H J, Kang, R, Lotze, M T, Tang, D

    Published in Cell death & disease (01-12-2013)
    “…Resistance to ‘apoptotic’ cell death is one of the major hallmarks of cancer, contributing to tumor development and therapeutic resistance. Damage-associated…”
    Get full text
    Journal Article
  4. 4

    HMGB1 release and redox regulates autophagy and apoptosis in cancer cells by Tang, D, Kang, R, Cheh, C-W, Livesey, K M, Liang, X, Schapiro, N E, Benschop, R, Sparvero, L J, Amoscato, A A, Tracey, K J, Zeh, H J, Lotze, M T

    Published in Oncogene (23-09-2010)
    “…The functional relationship and cross-regulation between autophagy and apoptosis is complex. In this study we show that the high-mobility group box 1 protein…”
    Get full text
    Journal Article
  5. 5

    The receptor for advanced glycation end products (RAGE) sustains autophagy and limits apoptosis, promoting pancreatic tumor cell survival by Kang, R, Tang, D, Schapiro, N E, Livesey, K M, Farkas, A, Loughran, P, Bierhaus, A, Lotze, M T, Zeh, H J

    Published in Cell death and differentiation (01-04-2010)
    “…Activation of the induced receptor for advanced glycation end products (RAGE) leads to initiation of NF- κ B and MAP kinase signaling pathways, resulting in…”
    Get full text
    Journal Article
  6. 6

    The receptor for advanced glycation end products (RAGE) enhances autophagy and neutrophil extracellular traps in pancreatic cancer by Boone, B A, Orlichenko, L, Schapiro, N E, Loughran, P, Gianfrate, G C, Ellis, J T, Singhi, A D, Kang, R, Tang, D, Lotze, M T, Zeh, H J

    Published in Cancer gene therapy (01-06-2015)
    “…Neutrophil extracellular traps (NETs) are formed when neutrophils expel their DNA, histones and intracellular proteins into the extracellular space or…”
    Get full text
    Journal Article
  7. 7

    RAGE is essential for oncogenic KRAS-mediated hypoxic signaling in pancreatic cancer by Kang, R, Hou, W, Zhang, Q, Chen, R, Lee, Y J, Bartlett, D L, Lotze, M T, Tang, D, Zeh, H J

    Published in Cell death & disease (23-10-2014)
    “…A hypoxic tumor microenvironment is characteristic of many cancer types, including one of the most lethal, pancreatic cancer. We recently demonstrated that the…”
    Get full text
    Journal Article
  8. 8

    Apoptosis promotes early tumorigenesis by Tang, D, Lotze, M T, Kang, R, Zeh, H J

    Published in Oncogene (21-04-2011)
    “…One hallmark of cancer is intrinsic or acquired resistance to apoptosis. Surprisingly, recent studies demonstrate that CD95/Fas/Apo1 and p53 upregulated…”
    Get full text
    Journal Article
  9. 9

    High Avidity CTLs for Two Self-Antigens Demonstrate Superior In Vitro and In Vivo Antitumor Efficacy by Zeh, Herbert J., III, Perry-Lalley, Donna, Dudley, Mark E, Rosenberg, Steven A, Yang, James C

    Published in The Journal of immunology (1950) (15-01-1999)
    “…A majority of the human tumor-associated Ags characterized to date are derived from nonmutated "self"-proteins. Little is currently understood about the nature…”
    Get full text
    Journal Article
  10. 10

    Oncolytic virotherapy for ovarian carcinomatosis using a replication-selective vaccinia virus armed with a yeast cytosine deaminase gene by Chalikonda, S, Kivlen, M H, O'Malley, M E, (Eric) Dong, X D, McCart, J A, Gorry, M C, Yin, X-Y, Brown, C K, Zeh, H J, Guo, Z S, Bartlett, D L

    Published in Cancer gene therapy (01-02-2008)
    “…In this study, we assessed the ability of a highly tumor-selective oncolytic vaccinia virus armed with a yeast cytosine deaminase gene to infect and lyse human…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Robotic-Assisted Major Pancreatic Resection by Zeh, H.J., MD, Bartlett, David L., MD, Moser, A. James, MD

    Published in Advances in surgery (Chicago) (2011)
    “…Robotic-assisted major pancreatic resections allow recreation of time-tested open surgical procedures on a minimally invasive platform. Early outcomes from…”
    Get full text
    Journal Article
  13. 13

    Effective eradication of established murine tumors with IL-12 gene therapy using a polycistronic retroviral vector by Tahara, H, Zitvogel, L, Storkus, WJ, Zeh, HJ, 3rd, McKinney, TG, Schreiber, RD, Gubler, U, Robbins, PD, Lotze, MT

    Published in The Journal of immunology (1950) (15-06-1995)
    “…Our recent studies using IL-12 protein or fibroblasts genetically engineered to secrete IL-12 have demonstrated profound antitumor effects of IL-12 in murine…”
    Get full text
    Journal Article
  14. 14

    A new recombinant vaccinia with targeted deletion of three viral genes: its safety and efficacy as an oncolytic virus by YANG, S, GUO, Z. S, O'MALLEY, M. E, YIN, X, ZEH, H. J, BARTLETT, D. L

    Published in Gene therapy (01-04-2007)
    “…To enhance further the safety and efficacy of oncolytic vaccinia virus, we have developed a new virus with targeted deletions of three viral genes encoding…”
    Get full text
    Journal Article
  15. 15

    Fibroblasts genetically engineered to secrete interleukin 12 can suppress tumor growth and induce antitumor immunity to a murine melanoma in vivo by TAHARA, H, ZEH, J. H, STORKUS, W. J, PAPPO, I, WATKINS, S. C, GUBLER, WOLF, S. F, ROBBINS, P. D, LOTZE, M. T

    Published in Cancer research (Chicago, Ill.) (1994)
    “…Interleukin 12 (IL-12), a disulfide-linked heterodimeric cytokine produced primarily by macrophages, is composed of light (p35) and heavy (p40) chains. It…”
    Get full text
    Journal Article
  16. 16

    Algorithm-based care versus usual care for the early recognition and management of complications after pancreatic resection in the Netherlands: an open-label, nationwide, stepped-wedge cluster-randomised trial by Smits, F Jasmijn, Henry, Anne Claire, Besselink, Marc G, Busch, Olivier R, van Eijck, Casper H, Arntz, Mark, Bollen, Thomas L, van Delden, Otto M, van den Heuvel, Daniel, van der Leij, Christiaan, van Lienden, Krijn P, Moelker, Adriaan, Bonsing, Bert A, Borel Rinkes, Inne H, Bosscha, Koop, van Dam, Ronald M, Derksen, Wouter J M, den Dulk, Marcel, Festen, Sebastiaan, Groot Koerkamp, Bas, de Haas, Robbert J, Hagendoorn, Jeroen, van der Harst, Erwin, de Hingh, Ignace H, Kazemier, Geert, van der Kolk, Marion, Liem, Mike, Lips, Daan J, Luyer, Misha D, de Meijer, Vincent E, Mieog, J Sven, Nieuwenhuijs, Vincent B, Patijn, Gijs A, te Riele, Wouter W, Roos, Daphne, Schreinemakers, Jennifer M, Stommel, Martijn W J, Wit, Fennie, Zonderhuis, Babs A, Daamen, Lois A, van Werkhoven, C Henri, Molenaar, I Quintus, van Santvoort, Hjalmar C, Blomjous, JG, de Boer, MT, van den Boezem, P, Bouwense, S, Bruijnen, R, Buis, CI, del Chiaro, M, Coene, PP, Coolsen, M, Daams, F, Dejong, K, Draaisma, W, Eker, HH, Elsen, AH, Gerhards, MF, Hartog, H, Hoogwater, FJ, Imani, F, Jenniskens, S, de Jong, KP, Karsten, TM, Klaase, JM, de Kleine, RHJ, van Laarhoven, CJ, van der Lelij, H, Manusama, ER, Meerdink, M, Meijerink, M, Nederend, J, Nijkamp, MW, Nota, CL, Porte, RJ, Reef, J, de Reuver, P, van Rijswijk, C, Romkens, T, Rupert, C, van der Schelling, GP, Serafino, JP, Vos, LD, Vriens, MR, Beers-Vural, E, Wagtenberg, JM, Wijsman, JH, de Wilde, RF, Wolfgang, CL, Zeh, HJ

    Published in The Lancet (British edition) (14-05-2022)
    “…Early recognition and management of postoperative complications, before they become clinically relevant, can improve postoperative outcomes for patients,…”
    Get full text
    Journal Article
  17. 17

    Identification of human melanoma peptides recognized by class I restricted tumor infiltrating T lymphocytes by Storkus, WJ, Zeh, HJ, 3d, Maeurer, MJ, Salter, RD, Lotze, MT

    Published in The Journal of immunology (1950) (01-10-1993)
    “…Using a newly described pH 3.3 acid elution technique, peptides were extracted by denaturation of class I molecules on the surface of human melanomas. HPLC…”
    Get full text
    Journal Article
  18. 18

    Risk factors and outcomes of conversion in minimally invasive distal pancreatectomy: a systematic review by Balduzzi, A., van der Heijde, N., Alseidi, A., Dokmak, S., Kendrick, M. L., Polanco, P. M., Sandford, D. E., Shrikhande, S. V., Vollmer, C. M., Wang, S. E., Zeh, H. J., Hilal, M. Abu, Asbun, H. J., Besselink, M. G.

    Published in Langenbeck's archives of surgery (01-05-2021)
    “…Purpose The reported conversion rates for minimally invasive distal pancreatectomy (MIDP) range widely from 2 to 38%. The identification of risk factors for…”
    Get full text
    Journal Article
  19. 19

    Identification of T-cell epitopes: rapid isolation of class I-presented peptides from viable cells by mild acid elution by Storkus, W J, Zeh, 3rd, H J, Salter, R D, Lotze, M T

    “…A novel method was developed to isolate immunogenic peptides (CD8+ T-cell epitopes) from class I complexes expressed at the cell surface of viable cells. Cells…”
    Get more information
    Journal Article
  20. 20

    Vaccines for colorectal cancer by Zeh, Herbert J, Stavely-O'Carroll, Kevin, Choti, Michael A

    Published in Trends in Molecular Medicine (01-07-2001)
    “…Despite recent advances in the treatment of colorectal cancer, the overall survival rate for those patients with advanced locoregional disease remains less…”
    Get full text
    Book Review Journal Article